Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 25,426–25,450 of 27,380 studies, newest first · page 1018 of 1096.

July 2000 17

  1. 2000-07-01

    A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia

    ✓ Peer-reviewed Cognitive tests and assessment Dementia and geriatric cognitive disorders

    Key finding: The data were collected during a 52-week, double-blind, placebo-controlled, fixed dose, parallel-group, multicenter study. +3 more findings

  2. 2000-07-01

    Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial

    ✓ Peer-reviewed Cognitive tests and assessment Stroke

    Key finding: Patients with poststroke major depression have a greater severity of cognitive impairment than nondepressed patients even when matched for size and location of stroke lesion. +3 more findings

  3. 2000-07-01

    Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss

    ✓ Peer-reviewed Risk genes beyond APOE The American journal of pathology

    Key finding: Deposition of Abeta was detected as early as 3 months of age in the Fc and CA1 of PSAPP mice and progressed to cover 28.3% of the superior frontal cortex and 18.4% of CA1 at 12 months: approximately 20- (Fc) and approximately 40- (CA1) fold greater deposition than in APPsw mice. +3 more findings

  4. 2000-07-01

    Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

    ✓ Peer-reviewed Mild cognitive impairment Neurology

    Key finding: These findings suggest that the initial 1H MRS change in the pathologic progression of AD is an increase in MI/Cr. +3 more findings

  5. 2000-07-01

    Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

    ✓ Peer-reviewed Lewy body dementia Nature genetics

    Key finding: Our findings indicate that accumulation of proteins that have yet to be identified causes a selective neural cell death without formation of Lewy bodies. +1 more finding

  6. 2000-07-01

    Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neurobiology of aging

    Key finding: We have previously shown that Alzheimer disease (AD) brain exhibits terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) for DNA damage and morphological evidence for apoptosis. +4 more findings

  7. 2000-07-01

    Are hereditary hemochromatosis mutations involved in Alzheimer disease?

    ✓ Peer-reviewed Down syndrome and Alzheimer's American journal of medical genetics

    Key finding: Mutations in the class I-like major histocompatibility complex gene called HFE are associated with hereditary hemochromatosis (HHC), a disorder of excessive iron uptake. +2 more findings

  8. 2000-07-01

    Is depression a risk factor for dementia or cognitive decline? A review

    ✓ Peer-reviewed Risk factors Gerontology

    Key finding: There is sufficient evidence to take seriously the possibility that depression is a risk factor for dementia and cognitive decline. +1 more finding

  9. 2000-07-01

    The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong

    ✓ Peer-reviewed Digital health tools Annals of the Academy of Medicine, Singapore

    Key finding: The internal consistency (Cronbach's alpha) of the ADAS-cog were 0.91, 0.88 and 0.65 for the whole group, the AD and normal (i.e. non-demented) subjects respectively.

  10. 2000-07-01

    Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts

    ✓ Peer-reviewed How common it is Nature genetics

    Key finding: We have previously identified a shared 153-kb ancestor haplotype in all Finnish disease alleles between markers D19S1175 and D19S608 on chromosome 19q13.1 (refs 5,6). +4 more findings

  11. 2000-07-01

    Barriers to healthcare access for cognitively impaired older Hispanics

    ✓ Peer-reviewed Disparities Alzheimer disease and associated disorders

    Key finding: This study further reports the results of the BHAS applied to a community sample of cognitively impaired older Hispanics and their caregivers. +1 more finding

  12. 2000-07-01

    Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: Patients with anti-Ta (also called anti-Ma2) antibodies were young men with testicular tumours (100%), frequent hypothalamic involvement (70%) and a poor neurological outcome. +4 more findings

  13. 2000-07-01
  14. 2000-07-01
  15. 2000-07-01

    Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial

    ✓ Peer-reviewed Treatments Clinical therapeutics

    Key finding: The results of this study suggest that naftidrofuryl is effective and well tolerated in treating the symptoms of vascular and mixed dementia. +3 more findings

  16. 2000-07-01

    Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations

    ✓ Peer-reviewed Genetics The American journal of pathology

    Key finding: To evaluate endocytic activation, we used markers of internalization (rab5, rabaptin 5) and recycling (rab4), and found that enlargement of rab5-positive early endosomes in the AD brain was associated with elevated levels of rab4 immunoreactive protein and translocation of rabaptin 5 to endosomes, implying that both endocytic uptake and recycling are activated. +2 more findings

  17. 2000-07-01

    Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology

    ✓ Peer-reviewed Biomarkers International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

    Key finding: To elucidate the mechanisms involved in beta-amyloid-mediated inflammation, transgenic mice (Tg2576) expressing high levels of the Swedish double mutation of human amyloid precursor protein and progressively developing typical beta-amyloid plaques in cortical brain regions including gliosis and astrocytosis, were examined for the expression pattern of a number of cytokines. +4 more findings

June 2000 8

  1. 2000-06-21

    SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease

    ✓ Peer-reviewed Genetics American journal of human genetics

    Key finding: Our results demonstrate that associations can be detected at SNPs near a complex disease gene. +1 more finding

  2. 2000-06-01

    Clock-drawing: is it the ideal cognitive screening test?

    ✓ Peer-reviewed Cognitive tests and assessment International journal of geriatric psychiatry

    Key finding: The clock-drawing test meets defined criteria for a cognitive screening instrument. +3 more findings

  3. 2000-06-01

    How much do persons with Alzheimer's disease cost Medicare?

    ✓ Peer-reviewed Digital health tools Journal of the American Geriatrics Society

    Key finding: The average total cost to Medicare of persons with a claims-based diagnosis of AD was $6021 versus $2310 (P < .001) for persons without a diagnosis. +1 more finding

  4. 2000-06-01

    On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

    ✓ Peer-reviewed End-of-life care Experimental neurology

    Key finding: Bartus, Simple Words for Complex Lives, (c) 1998 In the nearly 20 years since the cholinergic hypothesis was initially formulated, significant progress has been achieved. +1 more finding

  5. 2000-06-01

    Inflamm-aging. An evolutionary perspective on immunosenescence

    ✓ Peer-reviewed Risk factors Annals of the New York Academy of Sciences

    Key finding: In conclusion, the beneficial effects of inflammation devoted to the neutralization of dangerous/harmful agents early in life and in adulthood become detrimental late in life in a period largely not foreseen by evolution, according to the antagonistic pleiotropy theory of aging.

  6. 2000-06-01

    Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1

    ✓ Peer-reviewed Risk genes beyond APOE Nature

    Key finding: There is evidence that the polytopic membrane-spanning proteins, presenilin 1 and 2 (PS1 and PS2), are important determinants of gamma-secretase activity: mutations in PS1 and PS2 that are associated with early-onset familial Alzheimer's disease increase the production of A beta42 (refs 4-6), the more amyloidogenic peptide; gamma-secretase activity is reduced in neuronal cultures derived from PS1-deficient mouse embryos; and directed mutagenesis of two conserved aspartates in transmembrane segments of PS1 inactivates the ability of gamma-secretase to catalyse processing of APP within its transmembrane domain. +2 more findings

  7. 2000-06-01

    From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy

    ✓ Peer-reviewed Hippocampus size on brain scans Annals of the New York Academy of Sciences

    Key finding: More importantly, the right EC, but not the left, was significantly smaller in elderly participants compared to young controls. +2 more findings

  8. 2000-06-01

    Hippocampal volume and everyday memory in children of very low birth weight

    ✓ Peer-reviewed Hippocampus size on brain scans Pediatric research

    Key finding: The preterm group had significantly smaller hippocampal volumes bilaterally, despite equivalent head size, and showed specific deficits in certain aspects of everyday memory, both on objective testing and as indicated by parental questionnaires.

Browse the library by subject, with the full score breakdown →